Pharma companies against plan to bring nutraceuticals under drug regulator

Controversy arises as government considers shifting nutraceuticals to drug regulatory authority from FSSAI oversight. Industry experts express reservations and call for detailed discussions. Nutraceutical segment set to reach $18 billion in India by 2025.